نتائج البحث - Sabine Brookman‐May

  • يعرض 1 - 11 نتائج من 11
تنقيح النتائج
  1. 1
    The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score

    The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pai... حسب Kurt Miller, Joan Carles, Jürgen E. Gschwend, Hendrik Van Poppel, Joris Diels, Sabine Brookman‐May

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU)

    Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic... حسب Sabine Brookman‐May, Riccardo Campi, José Daniel Subiela, Tobias Klatte, Johan F. Langenhuijsen, Maurizio Brausi, Estefanía Linares-Espinós, Alessandro Volpe, Martin Marszalek, Bülent Akdoğan, Christina Roll, Christian G. Stief, Óscar Rodríguez-Faba, Andrea Minervini

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study

    Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical... حسب Axel S. Merseburger, Neeraj Agarwal, Amitabha Bhaumik, Florence Lefresne, Laurence I. Karsh, Andrea Juliana Gomes, Álvaro Juárez Soto, Robert Given, Sabine Brookman‐May, Suneel Mundle, Sharon McCarthy, Hirotsugu Uemura, Simon Chowdhury, Kim N., Anders Bjartell

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy

    Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy... حسب Axel S. Merseburger, Neeraj Agarwal, Anders Bjartell, Hirotsugu Uemura, Álvaro Juárez Soto, Amitabha Bhaumik, Jürgen Böhm, Nguyen Toan Tran, Nils Krochmann, Mehregan Nematian‐Samani, Suneel Mundle, Sabine Brookman‐May, Angela Lopez‐Gitlitz, Sharon McCarthy, Kim Chi, Simon Chowdhury

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer

    Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in T... حسب S. Chowdhury, Anders Bjartell, Neeraj Agarwal, Byung Ha Chung, Robert Given, Andrea Juliana Gomes, Axel S. Merseburger, Mustafa Özgüroğlu, Álvaro Juárez Soto, Hirotsugu Uemura, D. Ye, Sabine Brookman‐May, Anil Londhe, Amitabha Bhaumik, Suneel Mundle, Julie S. Larsen, Sharon McCarthy, K.N. Chi

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Prostate-Specific Antigen (PSA) Decline with Apalutamide Therapy is Associated with Longer Survival and Improved Outcomes in Individuals with Metastatic Prostate Cancer: A Plain Language Summary of the TITAN Study

    Prostate-Specific Antigen (PSA) Decline with Apalutamide Therapy is Associated with Longer Survival and Improved Outcomes in Individuals with Metastatic Prostate Cancer: A Plain La... حسب Simon Chowdhury, Anders Bjartell, Neeraj Agarwal, Byung Ha Chung, Robert Given, Andrea Juliana Gomes, Axel S. Merseburger, Mustafa Özgüroğlu, Álvaro Juárez Soto, Hirotsugu Uemura, Dingwei Ye, Sabine Brookman‐May, Anil Londhe, Amitabha Bhaumik, Suneel Mundle, Julie S. Larsen, Sharon McCarthy, Kim N.

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Apalutamide and Overall Survival in Prostate Cancer

    Apalutamide and Overall Survival in Prostate Cancer حسب Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Peter De Porre, Alexis K. Smith, Sabine Brookman‐May, Susan Li, Ke Zhang, Brendan Rooney, Angela Lopez‐Gitlitz, Eric J. Small

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

    Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study حسب Kim N., Simon Chowdhury, Anders Bjartell, Byung Ha Chung, Andrea Juliana Gomes, Robert Given, Álvaro Juárez, Axel S. Merseburger, Mustafa Özgüroğlu, Hirotsugu Uemura, Dingwei Ye, Sabine Brookman‐May, Suneel Mundle, Sharon McCarthy, Julie S. Larsen, Weili Sun, Katherine B. Bevans, Ke Zhang, Nibedita Bandyopadhyay, Neeraj Agarwal

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐centre database (<scp>CORONA</scp>/<scp>SATURN</scp>‐<scp>P</scp>roject)

    Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐cent... حسب Sabine Brookman‐May, Matthias May, Shahrokh F. Shariat, Giacomo Novara, Richard Zigeuner, Luca Cindolo, Ottavio De Cobelli, Cosimo De Nunzio, Sascha Pahernik, Manfred P. Wirth, Nicola Longo, Alchiede Simonato, Sergio Serni, Salvatore Siracusano, Alessandro Volpe, Giuseppe Morgia, Roberto Bertini, Orietta Dalpiaz, Christian G. Stief, Vincenzo Ficarra

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

    Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo... حسب Fred Saad, Eleni Efstathiou, Gerhardt Attard, Thomas W. Flaig, Fábio Franke, Oscar B. Goodman, Stéphane Oudard, Thomas Steuber, Hiroyoshi Suzuki, Daphne Wu, Kesav Yeruva, Peter De Porre, Sabine Brookman‐May, Susan Li, Jinhui Li, Shibu Thomas, Katherine B. Bevans, Suneel Mundle, Sharon McCarthy, Dana E. Rathkopf

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    584P Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA + AAP) vs AAP in metastatic castration-resistant prostate cancer (mCRPC)

    584P Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA + AAP) vs AAP in metastatic castration-resistant... حسب Stéphane Oudard, Katherine B. Bevans, Gerhardt Attard, Eleni Efstathiou, Thomas W. Flaig, Fábio Franke, Oscar B. Goodman, Ugo De Giorgi, Christopher Pieczonka, Kesav Yeruva, Peter De Porre, Sabine Brookman‐May, Shiva Dibaj, Daphne Wu, Suneel Mundle, Sharon McCarthy, Thomas Steuber, Hidenori Suzuki, Dana E. Rathkopf, Fred Saad

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: